Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OBINUTUZUMAB vs OFATUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OBINUTUZUMAB vs OFATUMUMAB: Safety Overview

Metric OBINUTUZUMAB OFATUMUMAB
Total FAERS Reports 14,189 29,913
Deaths Reported 1,919 695
Death Rate 13.5% 2.3%
Hospitalizations 5,419 3,616
Average Patient Age 63.8 yrs 47.5 yrs
% Female Patients 41.7% 74.9%
Manufacturer Genentech, Inc. Novartis Pharmaceuticals Corporation
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription